← Back to Search

e-health application for Autism Spectrum Disorder

Waitlist Available
Led By Jan Willem Gorter, MD,PhD,FRCPC
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 6-month visit
Awards & highlights

Study Summary

This trial is testing whether the MyREADY Transition[TM] BBD App is helpful for brain-based disabilities, compared to not using it. Participants will either use the App or not, as usual care continues. The study team wants to see if the App helps youth be more knowledgeable about their own health.

Eligible Conditions
  • Autism Spectrum Disorder
  • Epilepsy
  • Cerebral Palsy
  • Autism
  • Fetal Alcohol Spectrum Disorders
  • Spina Bifida


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Transition Readiness Assessment Questionnaire (TRAQ) Change
Secondary outcome measures
Canadian Occupational Performance Measure (COPM) Change
Health Utilities Index® (Hui2/3) Proxy-Assessed Change
Measure of Process of Care (MPOC) Change
+4 more
Other outcome measures
Utilization of Intervention (Usage, Adherence, and Fidelity)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care + MyREADYTransition[TM] BBD AppExperimental Treatment1 Intervention
Participants in the experimental Intervention group continue to get the same care they have been getting (their usual care) and they receive the MyREADY Transition[TM] BBD App e-health application. There are 19 parts in the App with videos and games to help youth learn and practice ways to manage their health. There are approximately 5-7 hours of content in total. Participants will be asked to wait at least one day between the parts. There is a timer in the App to help to moderate pace and align with how young people learn and digest information. Participants can choose how much time they want to take to do the App. It is recommended that participants make their own routine for using it. The recommended shortest and longest intervention exposure times are: 1 part each day (this will take 19 days to do all of the App), 1 part each week (this will take 19 weeks to do all of the App).
Group II: Control Group: Usual CareActive Control1 Intervention
Participants in the no intervention Control group continue to get the same care they have been getting (their usual care). The researchers aim to supply the App to participants in both the intervention and control group for a limited time after participation in the study.

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
891 Previous Clinical Trials
2,605,414 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
561 Patients Enrolled for Autism Spectrum Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,348 Previous Clinical Trials
26,455,105 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
580 Patients Enrolled for Autism Spectrum Disorder
McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER
449 Previous Clinical Trials
159,794 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
350 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
What site did they apply to?
Lawson Health Research Institute
How many prior treatments have patients received?

What questions have other patients asked about this trial?

PatientReceived 2+ prior treatments

Why did patients apply to this trial?

PatientReceived no prior treatments
~11 spots leftby May 2025